VA
VR Adviser’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.2M | Hold |
2,685,448
| – | – | 3.01% | 9 |
|
|
2025
Q1 | $43.3M | Hold |
2,685,448
| – | – | 3.69% | 8 |
|
|
2024
Q4 | $62.5M | Hold |
2,685,448
| – | – | 4.29% | 7 |
|
|
2024
Q3 | $79M | Hold |
2,685,448
| – | – | 4.14% | 6 |
|
|
2024
Q2 | $63.1M | Buy |
2,685,448
+513,666
| +24% | +$12.1M | 4.02% | 9 |
|
|
2024
Q1 | $82.4M | Sell |
2,171,782
-200,932
| -8% | -$7.62M | 3.92% | 4 |
|
|
2023
Q4 | $51.1M | Buy |
2,372,714
+2,077,680
| +704% | +$44.7M | 3.5% | 8 |
|
|
2023
Q3 | $3.61M | Sell |
295,034
-6,048,187
| -95% | -$74.1M | 0.38% | 33 |
|
|
2023
Q2 | $2.86M | Buy |
+6,343,221
| New | +$2.86M | 0.46% | 26 |
|